InsiderClue
← All stocks

RECURSION PHARMACEUTICALS, INC.

RXRX Scheduled selling only
CIK 0001601830 #2125 in the set updated 17 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$8.93M
$5.09M on a plan · $3.84M straight out of an exercise
Sold at will
$0.00
0 of 36 sales
Net
−$8.93M
$0.00 against sales at will

By person

14 insiders · 36 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Borgeson Blake
Director
—
$4.10M (10) scheduled
−$4.10M
6,158,287
1.15%
$21.66M
−13.5%
Gibson Christopher
Director
—
$3.84M (17) scheduled
−$3.84M
883,735
0.1651%
$3.11M
+15.9%
Khan Najat
CEO and President
—
$806.53K (4) scheduled
−$806.53K
2,072,890
0.3872%
$7.29M
+317.1%
Taylor Ben R
Chief Financial Officer
—
$157.70K (3) scheduled
−$157.70K
1,071,462
0.2001%
$3.77M
+115.8%
Bumpus Namandje
Director
—
$28.13K (2) scheduled
−$28.13K
127,632
0.0238%
$448.96K
—
Secora Michael
Chief Financial Officer
—
—
—
1,487,694
0.2779%
$5.23M
+6.1%
Li Dean Y
Director
—
—
—
1,473,329
0.2752%
$5.18M
+9.6%
Hallett David
Chief Scientific Officer
—
—
—
1,043,837
0.1950%
$3.67M
+75.7%
Marriott Tina
President and COO
—
—
—
506,852
0.0947%
$1.78M
−2.7%
Dar Zavain
Director
—
—
—
240,764
0.0450%
$846.91K
+131.5%
Mauro David J
Chief Medical Officer
—
—
—
225,429
0.0421%
$792.97K
−1.8%
Michor Franziska
Director
—
—
—
215,477
0.0403%
$757.96K
—
HERSHBERG ROBERT
Director
—
—
—
162,156
0.0303%
$570.40K
+213.6%
Sun Elaine D
Director
—
—
—
135,981
0.0254%
$478.33K
—

Individual transactions

19
Insider
Date
Role
Action
Shares
Price
Amount
Khan Najat
8 Sep 2026
CEO and President
Sold on a plan
22,408
$3.52
$78.82K
Borgeson Blake
1 Sep 2026
Director
Sold on a plan
30,000
$3.34
$100.20K
Borgeson Blake
4 Aug 2026
Director
Sold on a plan
30,000
$3.25
$97.50K
Borgeson Blake
7 Jul 2026
Director
Sold on a plan
40,000
$3.96
$158.50K
Bumpus Namandje
18 Jun 2026
Director
Sold on a plan
3,963
$3.18
$12.60K
Khan Najat
5 Jun 2026
CEO and President
Sold on a plan
23,588
$3.58
$84.46K
Bumpus Namandje
3 Jun 2026
Director
Sold on a plan
4,386
$3.54
$15.53K
Borgeson Blake
2 Jun 2026
Director
Sold on a plan
30,000
$3.68
$110.40K
Borgeson Blake
5 May 2026
Director
Sold on a plan
30,000
$3.52
$105.60K
Borgeson Blake
7 Apr 2026
Director
Sold on a plan
30,000
$3.10
$93.00K
Taylor Ben R
17 Mar 2026
Chief Financial Officer
Sold on a plan
7,956
$3.39
$26.97K
Khan Najat
9 Mar 2026
CEO and President
Sold on a plan
28,298
$3.35
$94.66K
Borgeson Blake
3 Mar 2026
Director
Sold on a plan
170,000
$3.46
$588.20K
Taylor Ben R
18 Feb 2026
Chief Financial Officer
Sold on a plan
13,426
$3.08
$41.35K
Borgeson Blake
3 Feb 2026
Director
Sold on a plan
220,000
$4.20
$924.00K
Borgeson Blake
6 Jan 2026
Director
Sold on a plan
220,000
$4.36
$959.20K
Taylor Ben R
29 Dec 2025
Chief Financial Officer
Sold on a plan
21,383
$4.18
$89.38K
Khan Najat
22 Dec 2025
Chief R&D Commercial Officer
Sold on a plan
124,403
$4.41
$548.59K
Borgeson Blake
2 Dec 2025
Director
Sold on a plan
220,000
$4.37
$961.40K
Show all 36 transactions →

What was left out

Form 4 filings counted 72
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 19
Sales straight out of an exercise 17
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 5,086,226
History held since 19 Apr 2021